DOI: 10.3390/cancers15164162 ISSN:

Advances in the Radiological Evaluation of and Theranostics for Glioblastoma

Grayson W. Hooper, Shehbaz Ansari, Jason M. Johnson, Daniel T. Ginat
  • Cancer Research
  • Oncology

Imaging is essential for evaluating patients with glioblastoma. Traditionally a multimodality undertaking, CT, including CT cerebral blood profusion, PET/CT with traditional fluorine-18 fluorodeoxyglucose (18F-FDG), and MRI have been the mainstays for diagnosis and post-therapeutic assessment. However, recent advances in these modalities, in league with the emerging fields of radiomics and theranostics, may prove helpful in improving diagnostic accuracy and treating the disease.

More from our Archive